Assessment of syndromic management of curable sexually transmitted and reproductive tract infections among pregnant women: an observational cross-sectional study.
Adult
Coinfection
/ diagnosis
Cross-Sectional Studies
Female
Gonorrhea
/ diagnosis
Humans
Logistic Models
Multivariate Analysis
Pregnancy
Pregnancy Complications, Infectious
/ epidemiology
Prenatal Care
Prevalence
Reproductive Tract Infections
/ diagnosis
Rural Population
Sexually Transmitted Diseases
/ diagnosis
Socioeconomic Factors
Syphilis
/ epidemiology
Trichomonas Infections
/ epidemiology
Vaginosis, Bacterial
/ epidemiology
Young Adult
Zambia
/ epidemiology
Bacterial vaginosis
Prevalence
Reproductive tract infections
Risk factors
Sexually transmitted infections
Sub-Saharan Africa
Syndromic management
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
30 Jan 2021
30 Jan 2021
Historique:
received:
21
04
2020
accepted:
19
01
2021
entrez:
31
1
2021
pubmed:
1
2
2021
medline:
9
2
2021
Statut:
epublish
Résumé
This study estimated the prevalence of curable sexually transmitted and reproductive tract infections (STIs/RTIs) among pregnant women attending antenatal care (ANC) in rural Zambia, evaluated the effectiveness of syndromic management of STIs/RTIs versus reference-standard laboratory diagnoses, and identified determinants of curable STIs/RTIs during pregnancy. A total of 1086 pregnant women were enrolled at ANC booking, socio-demographic information and biological samples were collected, and the provision of syndromic management based care was documented. The Piot-Fransen model was used to evaluate the effectiveness of syndromic management versus etiological testing, and univariate and multivariate logistic regression analyses were used to identify determinants of STIs/RTIs. Participants had a mean age of 25.6 years and a mean gestational age of 22.0 weeks. Of 1084 women, 700 had at least one STI/RTI (64.6%; 95% confidence interval [CI], 61.7, 67.4). Only 10.2% of infected women received any treatment for a curable STI/RTI (excluding syphilis). Treatment was given to 0 of 56 women with chlamydia (prevalence 5.2%; 95% CI, 4.0, 6.6), 14.7% of participants with gonorrhoea (prevalence 3.1%; 95% CI, 2.2, 4.4), 7.8% of trichomoniasis positives (prevalence 24.8%; 95% CI, 22.3, 27.5) and 7.5% of women with bacterial vaginosis (prevalence 48.7%; 95% CI, 45.2, 51.2). An estimated 7.1% (95% CI, 5.6, 8.7) of participants had syphilis and received treatment. Women < 20 years old were more likely (adjusted odds ratio [aOR] = 5.01; 95% CI: 1.23, 19.44) to have gonorrhoea compared to women ≥30. The odds of trichomoniasis infection were highest among primigravidae (aOR = 2.40; 95% CI: 1.69, 3.40), decreasing with each subsequent pregnancy. Women 20 to 29 years old were more likely to be diagnosed with bacterial vaginosis compared to women ≥30 (aOR = 1.58; 95% CI: 1.19, 2.10). Women aged 20 to 29 and ≥ 30 years had higher odds of infection with syphilis, aOR = 3.96; 95% CI: 1.40, 11.20 and aOR = 3.29; 95% CI: 1.11, 9.74 respectively, compared to women under 20. Curable STIs/RTIs were common and the majority of cases were undetected and untreated. Alternative approaches are urgently needed in the ANC setting in rural Zambia.
Sections du résumé
BACKGROUND
BACKGROUND
This study estimated the prevalence of curable sexually transmitted and reproductive tract infections (STIs/RTIs) among pregnant women attending antenatal care (ANC) in rural Zambia, evaluated the effectiveness of syndromic management of STIs/RTIs versus reference-standard laboratory diagnoses, and identified determinants of curable STIs/RTIs during pregnancy.
METHODS
METHODS
A total of 1086 pregnant women were enrolled at ANC booking, socio-demographic information and biological samples were collected, and the provision of syndromic management based care was documented. The Piot-Fransen model was used to evaluate the effectiveness of syndromic management versus etiological testing, and univariate and multivariate logistic regression analyses were used to identify determinants of STIs/RTIs.
RESULTS
RESULTS
Participants had a mean age of 25.6 years and a mean gestational age of 22.0 weeks. Of 1084 women, 700 had at least one STI/RTI (64.6%; 95% confidence interval [CI], 61.7, 67.4). Only 10.2% of infected women received any treatment for a curable STI/RTI (excluding syphilis). Treatment was given to 0 of 56 women with chlamydia (prevalence 5.2%; 95% CI, 4.0, 6.6), 14.7% of participants with gonorrhoea (prevalence 3.1%; 95% CI, 2.2, 4.4), 7.8% of trichomoniasis positives (prevalence 24.8%; 95% CI, 22.3, 27.5) and 7.5% of women with bacterial vaginosis (prevalence 48.7%; 95% CI, 45.2, 51.2). An estimated 7.1% (95% CI, 5.6, 8.7) of participants had syphilis and received treatment. Women < 20 years old were more likely (adjusted odds ratio [aOR] = 5.01; 95% CI: 1.23, 19.44) to have gonorrhoea compared to women ≥30. The odds of trichomoniasis infection were highest among primigravidae (aOR = 2.40; 95% CI: 1.69, 3.40), decreasing with each subsequent pregnancy. Women 20 to 29 years old were more likely to be diagnosed with bacterial vaginosis compared to women ≥30 (aOR = 1.58; 95% CI: 1.19, 2.10). Women aged 20 to 29 and ≥ 30 years had higher odds of infection with syphilis, aOR = 3.96; 95% CI: 1.40, 11.20 and aOR = 3.29; 95% CI: 1.11, 9.74 respectively, compared to women under 20.
CONCLUSIONS
CONCLUSIONS
Curable STIs/RTIs were common and the majority of cases were undetected and untreated. Alternative approaches are urgently needed in the ANC setting in rural Zambia.
Identifiants
pubmed: 33516183
doi: 10.1186/s12884-021-03573-3
pii: 10.1186/s12884-021-03573-3
pmc: PMC7847014
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
98Références
Int J STD AIDS. 2018 Mar;29(4):324-333
pubmed: 28799824
BMC Infect Dis. 2007 Apr 16;7:27
pubmed: 17437632
J Clin Microbiol. 1991 Feb;29(2):297-301
pubmed: 1706728
Sex Transm Infect. 2009 Sep;85(5):370-5
pubmed: 19473997
Infect Dis Obstet Gynecol. 2018 May 9;2018:3946862
pubmed: 29861622
Expert Rev Anti Infect Ther. 2013 Dec;11(12):1303-32
pubmed: 24191955
Infect Dis Obstet Gynecol. 2010;2010:
pubmed: 20706691
Sex Transm Dis. 2015 Oct;42(10):554-65
pubmed: 26372927
Malar J. 2015 Sep 30;14:380
pubmed: 26423819
BMJ. 2017 Aug 25;358:j3973
pubmed: 28842528
Immunol Invest. 1997 Jan-Feb;26(1-2):157-61
pubmed: 9037620
J Infect Dis. 2002 Oct 1;186(7):940-7
pubmed: 12232834
Sex Transm Infect. 2015 May;91(3):194-200
pubmed: 25313204
J Clin Microbiol. 2017 Dec;55(12):3563-3565
pubmed: 29021154
Sex Transm Dis. 2016 Jul;43(7):450-8
pubmed: 27322048
Infect Dis Obstet Gynecol. 2001;9(3):133-41
pubmed: 11516061
PLoS One. 2019 Feb 27;14(2):e0211720
pubmed: 30811406
JAMA. 1986 Oct 10;256(14):1899-903
pubmed: 3761496
Sex Transm Infect. 2002 Feb;78(1):72
pubmed: 11872872
J Infect Dis. 1990 Mar;161(3):531-6
pubmed: 2313131
AIDS. 2001 Aug;15 Suppl 4:S79-88
pubmed: 11686469
Obstet Gynecol. 2001 Oct;98(4):656-63
pubmed: 11576584
J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):123-131
pubmed: 28737591
Cell Mol Biol (Noisy-le-grand). 1994 Sep;40(6):819-31
pubmed: 7812190
Trop Med Int Health. 2001 Dec;6(12):971-9
pubmed: 11737832
S Afr Med J. 2008 Jan;98(1):49-51
pubmed: 18270642
Trop Med Int Health. 2003 Jun;8(6):544-51
pubmed: 12791060
East Afr J Public Health. 2009 Dec;6(3):263-7
pubmed: 20803916
Am J Trop Med Hyg. 2016 Nov 2;95(5):1069-1076
pubmed: 27672205
Br J Vener Dis. 1982 Dec;58(6):355-8
pubmed: 6756542
Infect Dis Obstet Gynecol. 2016;2016:4386127
pubmed: 27313440
Am J Epidemiol. 1989 Jun;129(6):1247-57
pubmed: 2729260
AIDS. 2015 Sep 24;29(15):2025-33
pubmed: 26352880
Clin Infect Dis. 2002 Oct 15;35(Suppl 2):S200-9
pubmed: 12353207
Sex Transm Dis. 2020 Dec;47(12):779-789
pubmed: 32773611
JAMA. 2012 May 16;307(19):2079-86
pubmed: 22665107
World Health Organ Tech Rep Ser. 1991;810:1-103
pubmed: 1746163